SPL 9.20% 9.5¢ starpharma holdings limited

Ann: Investor Webinar Notification SPL Medicxi Partnership, page-15

  1. 2,245 Posts.
    lightbulb Created with Sketch. 323
    Sarge, what this deal is going to do is preserve the bottom line for SPL, because the R&D teams that currently are being paid by SPL are reaching the end of their work as the Ph2 Trials are all but done and it seems there is no other potential products in the pipeline within SPL.

    This R&D team will now shift focus to this new product that will be paid for by Petalion. Therefore, cash burn at SPL will reduce and therefore less risk of cap raises.....
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.